Tools & Resources

• Exercise and Psoriasis
• Is Your Psoriasis Under Control?
• Photos: Psoriasis Triggers
• Moderate to Severe Psoriasis
• Life With Psoriasis
• Makeup Tips for Psoriasis

NewsRelated to Psoriasis

31. Psoriasis May Raise Cardiovascular Risks
    
    June 15, 2009 -- People with psoriasis may need to pay close attention to their cardiovascular risks, a new study shows. The study, which appears in the June issue of Archives of Dermatology, looked at more than 5,700 patients at the Miami VA Medical Center, including 3,236 psoriasis patients. The p
    Read Full Article
32. Treat Psoriasis at Home: Ultraviolet Lamps
    
    May 7, 2009 -- Home treatment of the skin ailment psoriasis with ultraviolet light lamps is at least as safe and effective as conventional phototherapy at hospitals or clinics, according to new research. Ultraviolet B treatment involves exposing the skin to an artificial UVB light source. People fin
    Read Full Article
33. Psoriasis Linked to Hypertension, Diabetes
    
    April 20, 2009 -- Women who have the chronic skin condition psoriasis appear to be at higher risk of getting diabetes and high blood pressure, a new study shows. "We knew there was some association between psoriasis and diabetes and high blood pressure," says Abrar Qureshi, MD, MPH, assistant profes
    Read Full Article
34. Raptiva Pulled From Market
    
    April 8, 2009 - The psoriasis drug Raptiva has been voluntarily pulled from the market, drugmaker Genentech announced today. Raptiva suppresses the haywire immune responses that cause psoriasis. But this immune suppression sometimes allows a fatal infection, progressive multifocal leukoencephalopath
    Read Full Article
35. Psoriasis Drug Raptiva Tied to Brain Infection
    
    (Editor's note: On April 8, 2009, Genentech announced it was voluntarily pulling Raptiva from the market.) Feb. 19, 2009 -- The FDA today issued a public health advisory about reports of a rare brain infection in people using the psoriasis drug Raptiva. According to the FDA, there have been three co
    Read Full Article
36. Psoriasis Ointment Gets FDA Approval
    
    Feb. 3, 2009 -- A new psoriasis treatment, Vectical, is the first FDA-approved ointment containing calcitriol, the active form of vitamin D3. The FDA has approved Vectical for use by adults 18 and older with mild-to-moderate psoriasis. Studies in children are under way. There's still no cure for pso
    Read Full Article
37. Fat Hormone Linked to Psoriasis
    
    Dec. 15, 2008 - People with psoriasis may face a higher risk of obesity, metabolic syndrome, and other heart disease risk factors thanks to high levels of the so-called fat hormone leptin. A new study suggests that people with the common skin disease have higher levels of the hormone leptin, which r
    Read Full Article
38. Indigo Ointment Relieves Psoriasis
    
    Nov. 17, 2008 -- Psoriasis patients showed dramatic improvement after 12 weeks of treatment with an ointment containing indigo naturalis, a Chinese herbal remedy. The findings come from a study by Yin-Ku Lin, MD, of Chang Gung Memorial Hospital in Taipei, Taiwan, and colleagues. For more than five y
    Read Full Article
39. Psoriasis Drug Raptiva Gets FDA Warning
    
    (Editor's note: On April 8, 2009, Genentech announced it was voluntarily pulling Raptiva from the market.) Oct. 16, 2008 -- The psoriasis drug Raptiva is getting a "black box" warning, the FDA's sternest warning, about the risk of life-threatening infections including a rare brain infection and meni
    Read Full Article
40. Experimental Psoriasis Drug Takes on Enbrel
    
    Sept. 19, 2008 -- An experimental drug called ustekinumab shows better treatment results than an established drug, Enbrel, for treating moderate to severe plaque psoriasis in a new trial. In a news release, the drug company Centocor, which makes ustekinumab and sponsored the study, calls the new dru
    Read Full Article